SIMONINI, GABRIELE
 Distribuzione geografica
Continente #
NA - Nord America 8.399
EU - Europa 4.921
AS - Asia 1.475
AF - Africa 74
SA - Sud America 8
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.882
Nazione #
US - Stati Uniti d'America 8.361
RU - Federazione Russa 1.347
IE - Irlanda 938
IT - Italia 734
SE - Svezia 674
PL - Polonia 440
SG - Singapore 393
HK - Hong Kong 392
CN - Cina 276
IN - India 179
FI - Finlandia 167
DE - Germania 161
UA - Ucraina 125
GB - Regno Unito 101
JO - Giordania 91
TR - Turchia 82
ES - Italia 69
FR - Francia 63
CH - Svizzera 43
CA - Canada 34
CI - Costa d'Avorio 34
SC - Seychelles 28
AT - Austria 24
VN - Vietnam 17
IR - Iran 15
NL - Olanda 13
BE - Belgio 12
KR - Corea 7
SA - Arabia Saudita 6
CZ - Repubblica Ceca 5
EG - Egitto 5
IQ - Iraq 5
AU - Australia 4
BR - Brasile 4
KZ - Kazakistan 4
MU - Mauritius 4
PE - Perù 4
JP - Giappone 3
MX - Messico 3
EE - Estonia 2
ET - Etiopia 2
HR - Croazia 2
AZ - Azerbaigian 1
BH - Bahrain 1
CU - Cuba 1
EU - Europa 1
ID - Indonesia 1
IM - Isola di Man 1
MY - Malesia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 14.882
Città #
Fairfield 1.250
Dublin 930
Chandler 888
Ashburn 638
Woodbridge 540
Cambridge 499
Seattle 493
Houston 455
Wilmington 446
Warsaw 434
Lawrence 379
Altamura 373
Singapore 321
Princeton 292
Ann Arbor 198
Jacksonville 195
Boston 193
Hong Kong 183
Mumbai 126
Medford 112
Beijing 111
Buffalo 104
San Diego 94
Boardman 92
Moscow 82
Izmir 81
New York 78
Shanghai 63
Florence 59
Santa Clara 59
Barcelona 58
Falls Church 47
Kent 45
Bern 42
Norwalk 37
Milan 36
Pune 35
Abidjan 34
Hillsboro 29
Los Angeles 27
Vienna 24
Toronto 22
Frankfurt Am Main 20
Salerno 18
Dong Ket 17
Andover 16
London 14
Guangzhou 13
Chennai 10
Nanjing 10
Brussels 9
Kilburn 9
Munich 9
Verona 9
West Jordan 8
Helsinki 7
Seoul 7
Tehran 7
Washington 7
Dearborn 6
Lappeenranta 6
Naples 6
Philadelphia 6
A Coruña 5
Brno 5
Cairo 5
Erbil 5
Khobar 5
Laurel 5
Padova 5
Phoenix 5
Prato 5
Rome 5
Rui'an 5
Trieste 5
Véry 5
Amsterdam 4
Canicattì 4
Düsseldorf 4
Edmonton 4
Lima 4
Menlo Park 4
Palermo 4
Serra 4
Akron 3
Auburn Hills 3
Bologna 3
Fiesole 3
Hefei 3
Kish 3
Leuven 3
Montreal 3
New Bedfont 3
Pavia 3
Radomsko 3
Redmond 3
Redwood City 3
Romola 3
Scandicci 3
Shenzhen 3
Totale 10.563
Nome #
The intestinal microbiota in enthesitis-related arthitis 199
Alteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis. Associations with HLA-B27 Allele and Disease Status. 188
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-alpha therapy in childhood chronic uveitis. 166
Common symptoms for a rare disease in a girl with sarcoidosis: a case report 149
SAPHO syndrome in pediatric patients with inflammatory bowel disease treated with infliximab 138
Does switching anti-TNFα biologic agents represent an effective option in childhood chronic uveitis: The evidence from a systematic review and meta-analysis approach. 136
Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry. 135
Psoriatic juvenile idiopathic arthritis associated with uveitis: a case report. 134
Serum amyloid A circulating levels and disease activity in patients with juvenile idiopathic arthritis. 129
Serum osteopontin as a predictive marker of responsiveness to methotrexate in juvenile idiopathic arthritis. 128
T cell subpopulations in juvenile idiopathic arthritis and their modifications after biotherapies 124
Immunosuppressive Activity of Abatacept on Circulating T Helper Lymphocytes from Juvenile Idiopathic Arthritis Patients 121
Anti-adalimumab antibodies in a cohort of patients with juvenile idiopathic arthritis: incidence and clinical correlations 119
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin. 118
Kawasaki disease: an epidemiological study in central Italy 117
Identification of autoantibodies against inner ear antigens in a cohort of children with idiopathic sensorineural hearing loss. 115
Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium 112
Describing Kawasaki shock syndrome: results from a retrospective study and literature review 110
Mycophenolate mofetil as induction and long-term maintaining treatment in childhood: Primary angiitis of the central nervous system 109
Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach. 105
The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: Our experience and review of the literature. 103
Abatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritis. 103
Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis. 102
The common NOD2/CARD15 variant P268S in patients with non-infectious uveitis: a cohort study 99
A peptide-based anti-Adalimumab antibody assay to monitor immune response to biologics treatment in juvenile idiopathic arthritis and childhood chronic non-infectious uveitis 99
Systemic-onset juvenile idiopathic arthritis complicated by early onset amyloidosis in a patient carrying a mutation in the MEFV gene. 97
Glucocorticoids in the management of systemic juvenile idiopathic arthritis. 97
Kawasaki disease in infants less than one year of age: An Italian cohort from a single center 96
Sequential MR angiography in childhood primary angiitis of the CNS. 96
Oxidative stress in Systemic Sclerosis. 95
Early predictors of juvenile sacroiliitis in enthesitis-related arthritis. 95
Lack of association between the HLA-DRB1 locus and post-streptococcal reactive arthritis and acute rheumatic fever in italian children 94
Comparing ultraviolet light A photo(chemo)therapy with Methotrexate protocol in childhood localized scleroderma: Evidence from systematic review and meta-analysis approach 94
Loss of efficacy during long-term infliximab therapy for sight-threatening childhood uveitis. 93
Recent advances in the use of Anti-TNFα therapy for the treatment of juvenile idiopathic arthritis 93
Osteoprotegerin serum levels in children with type 1 diabetes: a potential modulating role in bone status. 92
Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis. 92
Coeliac disease in patients with Kawasaki disease. Is there a link? 91
Macrophage activation syndrome/Hemophagocytic Lymphohistiocytosis and Kawasaki disease. 91
Flares after withdrawal of biologic therapies in juvenile idiopathic arthritis: Clinical and laboratory correlates of remission duration 91
Clinical features and outcome of Cogan syndrome. 88
Joint pain management in children and adolescents 87
Pediatric Osteoporosis: Diagnosis and Treatment Considerations 87
Thyroid function, autoimmune thyroiditis and coeliac disease in juvenile idiopathic arthritis 86
Bone mass predictors in a large cohort of children with juvenile idiopathic arthritis (JIA) 86
Successful treatment with canakinumab of a paediatric patient with resistant Behçet's disease 86
Circulating leptin levels in juvenile idiopathic arthritis: a marker of nutritional status? 84
Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): State of the art and future perspectives. 83
Erratum to: Successful treatment with adalimumab for severe multifocal choroiditis and panuveitis in presumed (early-onset) ocular sarcoidosis 83
Anakinra treatment in drug-resistant Behcet's disease: a case series. 82
Severe cutaneous manifestations in a child with refractory Kawasaki disease. 81
Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. 80
Utility of magnetic resonance imaging when following up sacroiliitis in enthesitis-related arthritis. 80
Anticorpi anti-istone: È sempre lupus indotto da farmaci? 80
Diene-conjugates and antibodies against oxidized low-density lipoproteins in systemic sclerosis. 80
Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension. 78
Development and preliminary validation of a diagnostic score for identifying patients affected with adult-onset autoinflammatory disorders. 78
Sustained improvement of a girl affected with Devic’sdisease over 2 years of mycophenolate mofetil treatment 78
Acute febrile cholestasis as inaugural manifestation of Kawasaki’s disease. 77
Surface plasmon resonance-based methodology for anti-adalimumab antibody identification and kinetic characterization 77
Bone status over one-year etanercept treatment in juvenile idiopathic arthritis 76
Surgical abdomen with intestinal pseudo-obstruction as presenting feature of atypical Kawasaki disease. 75
Treatment strategies for childhood noninfectious chronic uveitis: an update. 74
Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis 74
Usefulness of wireless capsule endoscopy for detecting inflammatory bowel disease in children presenting with arthropathy. 74
Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis. 73
Childhood uveitis 72
Childhood chronic anterior uveitis associated with vernal keratoconjunctivitis (VKC): successful treatment with topical tacrolimus. Case series. 71
Differentiating PFAPA syndrome from monogenic periodic fevers. 71
Current therapeutic approaches to autoimmune chronic uveitis in children 70
Prevention of flare recurrences in childhood-refractory chronic uveitis: an open-label comparative study of adalimumab versus infliximab. 70
Changing evidence over time: Updated meta-analysis regarding anti-TNF efficacy in childhood chronic uveitis 70
Common variable immunodeficiency presenting as sarcoidosis in a 9-year-old child 70
Canakinumab for Childhood Sight-threatening Refractory Uveitis: A Case Series 69
No evidence yet to change American Heart Association recommendations for poststreptococcal reactive arthritis: comment on the article by van Bemmel et al. 69
Switching from Reference to Biosimilars Does Not Reduce Efficacy and Safety in Juvenile Idiopathic Arthritis 69
INCIDENCE OF OCCULT CANCER IN CHILDREN PRESENTING WITH MUSCULOSKELETAL SYMPTOMS: A 10-YEAR SURVEY IN A PEDIATRIC RHEUMATOLOGY UNIT 67
Diagnosing Kawasaki syndrome: the need for a new clinical tool. 67
Osteomielite cronica ricorrente in età pediatrica 67
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis. 67
Temporomandibular Joint Involvement in Association With Quality of Life, Disability, and High Disease Activity in Juvenile Idiopathic Arthritis 67
Bcl-2, p53 and c-myc expression in juvenile dermatomyositis. 66
Long-term efficacy of abatacept in pediatric patients with idiopathic uveitis: a case series 66
OBSIDIAn - real world evidence of Originator to BioSImilar Drug switch in juvenile idiopathic arthritis 65
Multifocal lymphadenopathy associated with severe Kawasaki disease: a difficult diagnosis. 65
Acute febrile cholestasis as an inaugural manifestation of kawasaki’s disease 64
Prebiologic Therapy Tuberculosis Screening Experience in a Pediatric Rheumatology Center: TST and IGRA Are Both Necessary 64
Circulating levels of the adipocytokines vaspin and omentin in patients with Kawasaki disease. 64
Bilateral renal artery stenosis in Kawasaki disease: a report of two cases. 63
Elbow monoarthritis: an atypical onset of juvenile idiopathic arthritis. 63
Current evidence of anti-tumor necrosis factor α treatment efficacy in childhood chronic uveitis: A systematic review and meta-analysis approach of individual drugs 63
Fast recovery of cardiac function in PIMS-TS patients early using intravenous anti-IL-1 treatment 63
Association of low bone mass with vitamin d receptor gene and calcitonin receptor gene polymorphisms in juvenile idiopathic arthritis. 63
Retinal capillaritis in a CRB1-associated retinal dystrophy 63
Le malattie reumatiche in età Pediatrica 62
NEPRILYSIN LEVELS IN PLASMA AND SYNOVIAL FLUID OF JUVENILE IDIOPATHIC ARTHRITIS PATIENTS. RHEUMATOL INT. 2005 JUN;25(5):336-40. EPUB 2004 MAR 3. 61
Recurrent orbital pain and diplopia in a 12 years old boy 61
Non-anti-TNF biologic modifier drugs in non-infectious refractory chronic uveitis: The current evidence from a systematic review 61
Long-term follow-up of coronary artery lesions in children in Kawasaki syndrome 61
AB1025 Chronic Recurrent Multifocal Osteomyelitis (CRMO): The Importance of an Accurate Differential Diagnosis 60
Totale 8.886
Categoria #
all - tutte 57.324
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.324


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.809 0 0 0 176 252 269 258 270 241 142 157 44
2020/20211.256 108 107 69 161 46 132 45 112 101 182 87 106
2021/20221.744 42 222 196 110 35 51 61 156 47 39 271 514
2022/20234.214 421 957 173 270 278 752 523 201 381 31 140 87
2023/20241.523 60 176 277 87 103 265 66 254 42 79 84 30
2024/20252.113 392 1.089 588 44 0 0 0 0 0 0 0 0
Totale 15.205